Feasibility of bremsstrahlung dosimetry for direct dose estimation in patients undergoing treatment with 90Y-ibritumomab tiuxetan

被引：0
|
作者：
C. Arrichiello
L. Aloj
M. Mormile
L. D’Ambrosio
F. Frigeri
C. Caracò
M. Arcamone
F. De Martinis
A. Pinto
S. Lastoria
机构：
[1] Istituto Nazionale per lo Studio e la Cura dei Tumori,Nuclear Medicine Department
[2] Fondazione “G. Pascale”,Hematology
[3] Istituto Nazionale per lo Studio e la Cura dei Tumori,Oncology and Stem Cells Transplantation Unit, Department of Hematology
[4] Fondazione “G. Pascale”,IRCCS
[5] Istituto Nazionale per lo Studio e la Cura dei Tumori,undefined
[6] Fondazione “G. Pascale”,undefined
来源：
European Journal of Nuclear Medicine and Molecular Imaging | 2012年 / 39卷
关键词：
Radioimmunotherapy; Ibritumomab tiuxetan; Non-Hodgkin’s lymphoma; Dosimetry; Bremsstrahlung imaging;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：956 / 966
页数：10
相关论文
共 50 条
  • [21] Imaging of the distribution of 90Y-ibritumomab tiuxetan in bone marrow and comparison with pathology
    Coulot, Jeremy
    Camara-Clayette, Valerie
    Ricard, Marcel
    Lavielle, Frederic
    Velasco, Valerie
    Drusch, Francoise
    Bosq, Jacques
    Schlumberger, Martin
    Ribrag, Vincent
    CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS, 2007, 22 (05) : 665 - 671
  • [22] Nursing a patient during and after 90Y-ibritumomab tiuxetan (Zevalin™) therapy
    Clayton, J
    LEUKEMIA & LYMPHOMA, 2003, 44 : S49 - S55
  • [23] Radioimmunotherapy with 90Y-ibritumomab tiuxetan for a hemodialysis patient with relapsed follicular lymphoma
    Fukuno, Kenji
    Tsurumi, Hisashi
    Yamada, Toshiki
    Iida, Takayoshi
    Takahashi, Takeshi
    Moriwaki, Hisataka
    LEUKEMIA & LYMPHOMA, 2013, 54 (12) : 2731 - 2733
  • [24] A theoretical dose-escalation study based on biological effective dose in radioimmunotherapy with 90Y-ibritumomab tiuxetan (Zevalin)
    Massimiliano Pacilio
    Margherita Betti
    Francesco Cicone
    Carolina Del Mastro
    Livia Montani
    Laura Chiacchiararelli
    Alessia Monaco
    Enrico Santini
    Francesco Scopinaro
    European Journal of Nuclear Medicine and Molecular Imaging, 2010, 37 : 862 - 873
  • [25] Quantification of Dose Nonuniformities by Voxel-Based Dosimetry in Patients Receiving 90Y-Ibritumomab-Tiuxetan
    Cicone, Francesco
    D'Arienzo, Marco
    Carpaneto, Andrea
    Russo, Eleonora
    Coniglio, Angela
    Delaloye, Angelika Bischof
    Scopinaro, Francesco
    CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS, 2013, 28 (02) : 98 - 107
  • [26] Use of 90Y-ibritumomab tiuxetan in non-Hodgkin's lymphoma
    Marcus, R
    SEMINARS IN ONCOLOGY, 2005, 32 (01) : S36 - S43
  • [27] A theoretical dose-escalation study based on biological effective dose in radioimmunotherapy with 90Y-ibritumomab tiuxetan (Zevalin)
    Pacilio, Massimiliano
    Betti, Margherita
    Cicone, Francesco
    Del Mastro, Carolina
    Montani, Livia
    Chiacchiararelli, Laura
    Monaco, Alessia
    Santini, Enrico
    Scopinaro, Francesco
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2010, 37 (05) : 862 - 873
  • [28] 90Y-ibritumomab tiuxetan (90Y-Zevalin) radioimmunotherapy as a consolidation strategy in mantle cell lymphoma (MCL) patients
    Jurczak, W.
    Giza, A.
    Hubalewska-Dydejczyk, A.
    Sowa-Staszczak, A.
    Glowa, B.
    Szostek, M.
    Krochmalczyk, D.
    Wegrzyn, J.
    Knopinska-Posluszny, W.
    Zdziarska, B.
    Kyrcz-Krzemien, S.
    Poplawska, L.
    Walewski, J.
    Wrobel, T.
    Skotnicki, A. B.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2007, 34 : S168 - S168
  • [29] Selecting patients for treatment with 90Y ibritumomab tiuxetan (Zevalin)
    Gregory, SA
    SEMINARS IN ONCOLOGY, 2003, 30 (06) : 17 - 22
  • [30] High-dose myeloablative 90Y-Ibritumomab Tiuxetan radioimmunotherapy with tandem stem-cell autografting
    Bombardieri, E.
    Devizzi, L.
    Seregni, E.
    DiNicola, M.
    Carlo-Stella, C.
    Matteucci, P.
    Chiesa, C.
    Maccauro, M.
    Gianni, A. M.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2006, 33 : S195 - S195
12345